
    
      PRIMARY OBJECTIVES:

      I. To study health-related quality of life (HRQoL, or QOL) for patients undergoing
      protocol-based bladder-preservation chemo-radiation.

      OUTLINE:

      Patients complete the European Organization for Research and Treatment for Cancer (EORTC)
      QLQ-Bladder Cancer Muscle Invasive (BLM-C30) at baseline, every 3 months for 1 year, every 4
      months for 1 year, every 6 months for 3 years, and then annually thereafter after completion
      of chemo-radiotherapy.
    
  